Seeking Alpha

Centient Biotech Investor » Articles » BEC |

More on BEC by Centient Biotech Investor
Articles by Ticker
A, AB, ABBI, ABI, ABPI, ABT, ACAD, ACEL, ACHN, ACOR, ACTC, ADH, ADLR, ADLS, ADZA, AFFY, AGEN, AGIX, AGN, AKN, AKZOY, ALKS, ALNY, ALXA, ALXN, AMGN, AMLN, ANDS, ANSV, ARAY, ARDM.OB, ARIA, ARKTF.PK, ARNA, ARRY, ARTE, ARXT, ASTM, AUXL, AVGN, AVNR, AVRX, AZN, BAX, BAYRY.PK, BCRX, BEC, BHRT, BIIB, BIOD,

Latest Comments on Centient Biotech Investor's Articles

  1. doctors2 on Bypassing Surgery - Will Stents Survive The Bad News?: If one recieved two JAJ Stents in one artery and one stent has... more »
  2. Neils808 on Boston Scientific Addresses Quality Issues at JPMorgan's HealthCare Conference: I disagree. BSX competes with Abbott and Cordis (J&J) for stenting... more »
  3. Bonnie Wyatt on Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth: This was a very informative article. more »
  4. Cowpens on Biotech Day in Review: Hopeful Results from HIV Conference: NVAX keeps working on it!! more »
  5. speed on Will Bayer Buy Onyx, Its Nexavar Partner?: NEXAVAR --the problem in it's price .. many people can't offer !!... more »
  6. speed on Will Bayer Buy Onyx, Its Nexavar Partner?: the problem in it's price .. many people can't offer !! how can I... more »
  7. User 176539 on Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division: Curagen "CRGN" is going to be one of those companies to blow your... more »
  8. User 192949 on Biotech Day in Review: Hopeful Results from HIV Conference: is a fastest service. more »
  9. Totally a biased short side opinion... on Biotech IPO Watch: Simcere Supplies High-End Generics In China: "seeking a Price/Revenue multiple of just 7 " This guy must be... more »
  10. jimmy Turano on Biotech Day In Review: Genentech Beats Estimates Slightly: OVERLOOKED NOW BY WALL STREET BUT THEY'RE IN FOR A BIG SURPRISE... more »
  11. jimmy Turano on Biotech Day In Review: Agilent Buys Stratagene For $245.5 Million: SEEKING THIRD PARTY OPINION FROM ASTUTE INVESTOR, WHO HAS THE... more »
  12. jimmy Turano on Biotech Day In Review: Roche Buys BioVeris For $600 Million: Can any experienced successful biotech investor either concur or... more »
  13. HS on Biotech in Review: Genentech Extends Uses for Avastin and Xeloda: test more »
  14. marcel.tony@orange.fr on Biotech Day In Review: Novartis Pulls Zelnorm Off The Market: Astellas is quite right : REGN has fantastic monoclonal... more »
  15. jon on Aradigm Revisited: CEO Adds Input to Analysis: The ticker symbol for Aradigm listed in the article is incorrect;... more »